» Articles » PMID: 10634519

Telomerase Activity in Ductal Carcinoma in Situ of the Breast

Overview
Specialty Oncology
Date 2000 Jan 14
PMID 10634519
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Telomerase plays an important role in maintaining the stability of the chromosomes. Activity of telomerase has been detected in proliferating and immortalized cell lines and in a number of malignant tumors including invasive breast cancer. The aim of the study was to examine telomerase activity in ductal carcinoma in situ (DCIS), which is considered to be a precursor lesion of infiltrating breast carcinoma, using a PCR-based telomerase activity protocol (TRAP). We examined 35 samples obtained from histologically confirmed breast biopsies, including 13 normal breast tissues, 11 infiltrating ductal carcinoma (IDC), nine DCIS, and two DCIS with microinvasion. Telomerase activity was demonstrated in 8/9 samples of DCIS, both samples of DCIS with microinvasion, and all but one sample of IDC. Normal breast tissue had no demonstrable telomerase activity. Our results indicate that telomerase is activated frequently in early breast carcinogenesis, although its utilization as a biomarker in DCIS is questionable.

Citing Articles

Association of hTERT expression, Her2Neu, estrogen receptors, progesterone receptors, with telomere length before and at the end of treatment in breast cancer patients.

Murillo-Ortiz B, Garcia-Corrales K, Martinez-Garza S, Romero-Vazquez M, Agustin-Godinez E, Escareno-Gomez A Front Med (Lausanne). 2024; 11:1450147.

PMID: 39188883 PMC: 11345256. DOI: 10.3389/fmed.2024.1450147.


Impact of khat (Catha edulis) and oral contraceptive use on telomerase levels and tumor suppressor genes p53 and p21 in normal subjects and breast cancer patients.

Atroosh F, Al-Habori M, Al-Eryani E, Saif-Ali R Sci Rep. 2024; 14(1):16365.

PMID: 39013992 PMC: 11252306. DOI: 10.1038/s41598-024-67355-5.


Anti(angiogenic) food components: can be a major source of bias in the investigation of angiogenesis inhibitors.

Rastmanesh R, Bowirrat A, Gupta A, Gilley E, Blum K Ann Transl Med. 2024; 11(12):419.

PMID: 38213800 PMC: 10777223. DOI: 10.21037/atm-23-1517.


Generation of Immortalised But Unstable Cells after hTERT Introduction in Telomere-Compromised and p53-Deficient vHMECs.

Bernal A, Zafon E, Dominguez D, Bertran E, Tusell L Int J Mol Sci. 2018; 19(7).

PMID: 30018248 PMC: 6073565. DOI: 10.3390/ijms19072078.


Telomere Length Dynamics and the Evolution of Cancer Genome Architecture.

Cleal K, Norris K, Baird D Int J Mol Sci. 2018; 19(2).

PMID: 29415479 PMC: 5855704. DOI: 10.3390/ijms19020482.